Table 4 The multivariate analysis for the OS.
OS | |||
|---|---|---|---|
HR | 95% CI | P value | |
Therapeutic regimen (control vs. experimental) | 0.567 | 0.288–1.117 | 0.101 |
BCLC (B vs. C) | 0.366 | 0.143–0.934 | 0.036 |
Extrahepatic metastasis (yes vs. no) | 0.964 | 0.478–1.945 | 0.918 |
Tumor differentiation (poorly vs. well and moderately) | 1.256 | 0.631–2.498 | 0.517 |
TB, µmol/L (≤ 20 vs. > 22) | 0.421 | 0.210–0.844 | 0.015 |
PT, second (≤ 16 vs. > 16) | 0.590 | 0.288–1.208 | 0.149 |
AFP, ng/ml (≤ 200 vs. > 200) | 0.479 | 0.234–0.979 | 0.043 |
